Articles on disposables: implementation, validation, cost-benefit analysis - BioPharm International


The advantages and disadvantages of disposables, along with cost-benefit analyses, validation strategies, and implementation approaches.

Lifecycle Cost Analysis for Single-Use Systems

November 2, 2008

This article describes a quick method for evaluating lifecycle costs for single-use systems against their more conventional stainless-steel counterparts.

The Environmental Impact of Disposable Technologies

November 2, 2008

Can disposables reduce your facility's environmental footprint? We have compared the environmental footprint of a traditional biopharmaceutical manufacturing facility using fixed-in-place stainless steel equipment, and a facility implementing disposable technologies for cell culture, solution mixing and hold, product hold, and liquid transfer.

Disposables for Bioprocessing: Making the Transition

November 2, 2008

Transitioning from stainless steel technology to disposable technology in bioprocessing.

Disposable Bioreactors for Cells and Microbes

November 2, 2008

Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.

The Environmental Impact of Disposables

November 1, 2008

Despite creating plastic waste, the disposables option is better for the environment.

The Challenges and Benefits of Disposable Technologies

November 1, 2008

Interview with David Radspinner, director of global marketing & customer applications, bioprocess production at Thermo Fisher Scientific.

Disposable Decisions

October 1, 2008

To achieve the right balance between disposable and reuseable options, companies must consider important technical and economic factors.

Disposables Open Up Possibilities in Facility Design

August 1, 2008

In addition to making technical developments, vendors are also looking at ways to improve supply-chain security. By offering standard, off-the-shelf products, vendors are able to shorten lead times and improve the security of supply.

How to Evaluate the Cost Impact of Using Disposables in Biomanufacturing

June 1, 2008

The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.



Click here